Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications

about

Pathological and molecular advances in pediatric low-grade astrocytoma Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.

P2860

Q27026123-5C5D5D1E-B358-4B29-88B8-A7F7302E6F55 Q37212868-76782BCB-803B-41E6-AD05-D91398FF7A10

P2860

Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications

Item

http://www.wikidata.org/entity/Q37947413

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Rosette forming glioneuronal t ...... : pathobiological implications

@en

Rosette forming glioneuronal t ...... pathobiological implications.

@nl

type

Item

label

Rosette forming glioneuronal t ...... : pathobiological implications

@en

Rosette forming glioneuronal t ...... pathobiological implications.

@nl

prefLabel

Rosette forming glioneuronal t ...... : pathobiological implications

@en

Rosette forming glioneuronal t ...... pathobiological implications.

@nl

P1476

Rosette forming glioneuronal t ...... : pathobiological implications

@en

P2093

C G Eberhart

http://www.w3.org/2001/XMLSchema#string

F J Rodriguez

http://www.w3.org/2001/XMLSchema#string

G I Jallo

http://www.w3.org/2001/XMLSchema#string

M Ayars

http://www.w3.org/2001/XMLSchema#string

M Karafin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

The 2007 WHO classification of tumours of the central nervous system

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.

Germline KRAS mutations cause Noonan syndrome

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

Primary mixed glioneuronal tumor of the central nervous system in a patient with noonan syndrome: a case report and review of the literature.

A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?

Germline gain-of-function mutations in RAF1 cause Noonan syndrome.

P304

297-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.5414/NP300374

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22011734

http://www.w3.org/2001/XMLSchema#string

P921

Noonan syndrome

brain cancer

P932

3657471

http://www.w3.org/2001/XMLSchema#string

Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications

about

P2860

P2860

Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932